Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure

Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure

The impact of body mass index (BMI) on treatment outcomes in patients with cancer is gaining increasing attention given the limited data available. The aim of this study was to investigate the contribution of BMI on the safety and efficacy profile of palbociclib in 134 patients with metastatic lumin...

Full description

Bibliographic Details
Main Authors: Rossana Roncato, Elena Peruzzi, Lorenzo Gerratana, Bianca Posocco, Sofia Nuzzo, Marcella Montico, Marco Orleni, Serena Corsetti, Michele Bartoletti, Sara Gagno, Giovanni Canil, Elena De Mattia, Jacopo Angelini, Massimo Baraldo, Fabio Puglisi, Erika Cecchin, Giuseppe Toffoli
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Palbociclib
Body mass index
Progression free survival
Treatment adherence
Hormon receptor-positive
HER-negative breast cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223006960

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223006960

Similar Items